Tirzepatide 60mg - 10 vial kit

Tirzepatide is a dual GLP-1 and GIP receptor agonist that engages two incretin pathways simultaneously, a design that has distinguished it from earlier single-receptor compounds in metabolic research. GLP-1 receptor activity contributes to satiety signaling and insulin secretion modulation, while GIP receptor engagement adds a complementary metabolic dimension that has been associated with enhanced body-composition outcomes in clinical study data. Tirzepatide has one of the most robust clinical research records of any compound currently in this category, with large-scale trials producing well-documented data across glucose regulation, body weight, and cardiovascular markers.

• Latest Janoshik Test Results

• Weight: .2 lbs
• Dimensions: 2 × 2 × 2 in
• MG: 15MG, 30MG, 60MG

There are no reviews yet.